07.02.20 / Frankfurt
Name: Bellerophon / Stock / Biotechnology & Medical Research / Micro Cap
Bellerophon Therapeutics Inc Stock
The community is currently still undecided about Bellerophon Therapeutics Inc with 1 Buy predictions and 0 Sell predictions.
Based on the current price of €0.29 the target price of €13.00 shows a potential of 4321.769% for Bellerophon Therapeutics Inc which would more than double the current price.
Pros and Cons of Bellerophon Therapeutics Inc in the next few years
Pros
?
Market Position
?
Conscious of the environment
?
Shareholder structure
Cons
?
Worthwhile Investment for the next years
?
Brand
?
Growth compared to competition
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Bellerophon Therapeutics Inc vs. its peers
| Security | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Bellerophon Therapeutics Inc | - | - | - | - | - | - | - |
| Bioanalyticial Systems Inc. | -5.360% | -14.516% | 23.256% | 144.240% | 26.190% | 550.307% | 670.909% |
| Northwest Biotherapeutics Inc. | 2.330% | 10.256% | 9.322% | - | -4.444% | - | - |
| ContraFect Corp. | -0.960% | -3.687% | -5.000% | -54.811% | 0.000% | - | - |